Phico: Pre-clinical and clinical development of intravenous Pseudomonas aeruginosa SASPject technology
IATI Identifier: US-EIN-04-2103547-Phico
Published on
- date_range Feb 01, 2021 - Apr 30, 2023
- autorenew Implementation (Status)
- mail Contact
- share Share
TBD
more_horiz
Sectors:
-
Infectious disease control
Participating Organisations
| Name | Type | Role |
|---|---|---|
| Phico | Private Sector | Implementing |
Transaction
| Transaction Value |
Provider
Receiver |
Type | Date |
|---|---|---|---|
| 759,765 USD (Valued at Jun 08, 2023) | Provider N/A Receiver N/A | Expenditure |
date_range
Jun 08, 2023
|
| 977,086 USD (Valued at Jun 08, 2023) | Provider N/A Receiver N/A | Expenditure |
date_range
Jun 08, 2023
|
Budget
1,736,851
USD
-
977,086 USD (Valued at Jun 08, 2023)date_range Jul 01, 2022 - Jun 30, 2023
-
759,765 USD (Valued at Jan 25, 2024)date_range Feb 01, 2021 - Feb 28, 2021
access_time
Updated on
Jan 25, 2024 22:43:42